Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. (IOVA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IOVA · as of Jun 8, 2026
Key Statistics
Explore Iovance Biotherapeutics, Inc. Data
iova stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 20 · Buy rate: 75.0%
The IOVA analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month price target is $4.00, representing -5.44% downside from the current price of $4.23.
Competitors & Peers
iova competitorsIOVA
ATXS
AVBP
CTMX
DNA
ERASStock Performance
Full HistoryAbout Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to erad…
what is iovance biotherapeutics, inc. · iova stock overview · iovance biotherapeutics, inc. company profile · who is iovance biotherapeutics, inc. ceo · iova NASDAQ · iovance biotherapeutics, inc. headquarters · iovance biotherapeutics, inc. business segments
About Stock Overview & Key Data
Iovance Biotherapeutics, Inc. (IOVA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 15, 2010. As of the latest trading session, IOVA stock price is $4.23, with a market capitalization of $1.5B. The stock has returned +91.40% over the past 12 months and +54.95% year-to-date.
According to 20 Wall Street analysts, the consensus rating for Iovance Biotherapeutics, Inc. stock is Buy, with an average 12-month price target of $4.00. In fiscal year 2025, Iovance Biotherapeutics, Inc. reported revenue of $263.5M and net income of -$391.0M. For detailed data — including Iovance Biotherapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Iovance Biotherapeutics, Inc. (IOVA) stock price is $4.23. The stock is traded on NASDAQ under the ticker symbol IOVA. The 52-week range is $1.66 – $5.63.